What is MiRus?
MiRus is a prominent player in the medical technology and life sciences sector, dedicated to pioneering innovative biomaterials, implants, procedural technologies, and patient monitoring solutions. The company's core focus areas encompass cardiovascular, orthopedic, spine, and structural heart diseases. At the heart of its technological prowess is a proprietary molybdenum-rhenium alloy platform, enabling the creation of medical devices that are notably stronger, more durable, and less invasive. These advanced solutions are engineered to enhance patient outcomes across a broad spectrum of care. MiRus actively engages in close collaboration with physicians and healthcare professionals, aiming to develop next-generation medical solutions that elevate the standard of care in various medical specialties, thereby improving treatment effectiveness, surgical efficiency, and long-term patient well-being.
How much funding has MiRus raised?
MiRus has raised a total of $1.6B across 3 funding rounds:
Debt
$1M
Unspecified
$65M
Stock/Share Issuance
$1.5B
Debt (2020): $1M with participation from PPP
Unspecified (2021): $65M led by Mammoth Scientific
Stock/Share Issuance (2026): $1.5B supported by Boston Scientific
Key Investors in MiRus
Boston Scientific
Boston Scientific is a global medical device company specializing in minimally invasive technologies across interventional specialties, providing advanced solutions like catheters and stents to healthcare providers worldwide.
Mammoth Scientific
Mammoth Scientific is an entity involved in the investment landscape, participating in funding rounds for innovative companies within the scientific and technological sectors.
PPP
Public-Private Partnership
What's next for MiRus?
With the recent influx of major strategic investment and a substantial overall capital base of $1.6B, MiRus is strategically positioned for accelerated growth and product development. The company's focus on its proprietary molybdenum-rhenium alloy platform suggests a continued emphasis on enhancing the durability and performance of medical implants and devices. Future endeavors will likely involve expanding the application of these technologies into new therapeutic areas and further refining their integration with digital health solutions. This significant backing indicates a strong market confidence in MiRus's vision to address complex clinical challenges and improve patient care through advanced medical technology.
See full MiRus company page
